论文部分内容阅读
具有我国自主知识产权的植入式多程控心脏起搏器专用电路,日前在西安交通大学医学院研制成功。该电路采用通用微处理器设计,研发成本低、周期短,极大地降低了投资风险,性能指标达到国外同类产品的先进水平,从而“特别适用于我国这样的发展中国家”。据介绍,程控起搏器专用电路是起搏器制造的核心技术。过去我国不掌握这项核心技术,因此研制具有我国自主知识产权的植入式多程控心脏起搏器专用电路,并以此为突破口,发展我国的起搏器工业,具有重要的社会和经济价值。
With our own intellectual property rights implantable multi-program-controlled cardiac pacemaker circuit, recently in Xi’an Jiaotong University School of Medicine successfully developed. The circuit uses a common microprocessor design, low R & D costs, short cycle, which greatly reduces the investment risk, performance indicators have reached the advanced level of similar foreign products, thus “particularly suitable for China, such a developing country.” According to reports, programmable pacemaker circuit is the core of pacemaker manufacturing technology. In the past, our country did not master this core technology, so we developed a dedicated circuit for implanted multi-programmed pacemaker with independent intellectual property rights in our country. Using this as a breakthrough, developing our country’s pacemaker industry has important social and economic value .